Company · CIK 1867096
Xeris Biopharma Holdings, Inc.
| CIK | 1867096 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | IL |
| Listed | XERS (Nasdaq) |
| First annual or quarterly report | 2021-11-10 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285597 | 2025-03-06 | 2025-05-13 | 2 | |
| 333-262404 | 2022-01-28 | 2022-05-11 | 3 | |
| 333-262403 | 2022-01-28 | 2022-02-07 | 2 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-05-13 | EFFECTDeclared effective | 333-285597 | 9999999995-25-001553 |
| 2025-03-06 | S-3Shelf registered | 333-285597 | 0001867096-25-000041 |
| 2022-05-11 | 424B5Shelf takedown | 333-262404 | 0001193125-22-147610 |
| 2022-02-07 | EFFECTDeclared effective | 333-262404 | 9999999995-22-000356 |
| 2022-02-07 | EFFECTDeclared effective | 333-262403 | 9999999995-22-000355 |
| 2022-01-28 | S-3Shelf registered | 333-262404 | 0001628280-22-001449 |
| 2022-01-28 | S-3Shelf registered | 333-262403 | 0001628280-22-001447 |
| 2021-07-29 | EFFECTDeclared effective | 333-257642 | 9999999995-21-002977 |